Language and content disclaimer
The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.
Linking to Non-Government of Canada Websites
Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.
Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.
View trial details
Overview
Official protocol title:
A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE EFFICACY AND SAFETY OF UPADACITINIB IN ADULT AND ADOLESCENT SUBJECTS WITH MODERATE TO SEVERE HIDRADENITIS SUPPURATIVA WHO HAVE FAILED ANTI-TNF THERAPY
Intervention/treatment:
Name given to the drug used in the clinical trial. This may be a code name, a chemical name of the active ingredient, a non-proprietary name or brand name.
UPADACITINIB (ABT-494)
Medical condition:
The disease or condition that's being studied in the clinical trial.
Protocol code:
An alpha-numeric sequence generated by the sponsor that can vary in length. Used as a reference to help identify a specific clinical trial protocol. Formerly referred to as 'protocol number'.
M23-698
Control number:
A unique 6-digit identification number Health Canada assigns to each clinical trial application.
273382
Status:
The status for the clinical trial as a whole. Note that the status for each site may be different and should always be confirmed with the clinical trial sponsor. Health Canada uses information provided by the sponsor to an international clinical trial registry to determine status values for each clinical trial. Status values on the portal can include:
• Not yet recruiting - Participants are not yet being recruited or enrolled at any site.
• Recruiting - Participants are currently being recruited.
• Active, not recruiting - The clinical trial is ongoing but new participants are not currently being recruited or enrolled.
• On hold - The clinical trial has been temporarily stopped, but it may start again.
• Closed - The clinical trial has either ended normally and participants are no longer being examined or treated, or it has stopped early and will not start again.
• Unknown - The status of the clinical trial has not been verified in the registry in the last 2 years. Please contact the sponsor.
• No match, ongoing - Please contact sponsor for status information.
• Other - Please contact sponsor for status information.
Active, not recruiting
Approved:
The date that the clinical trial has been determined to meet Health Canada’s regulatory requirements. For drug clinical trials, this means that a no objection letter or an authorization was issued.
May 30, 2023
Trial phase:
The stage of a clinical trial, based on factors such as the objectives of the trial and number of participants. Phase data displayed in the portal is taken from international registry data.
For more information see "Phases of drug trials" on the Definitions webpage
Phase 3
For more information:
ClinicalTrials.gov -
NCT05889182
This is an external link. The information is not authorized by the Government of Canada.
Eligibility
The characteristics people must have or the requirements they must meet to participate in the clinical trial. Eligibility criteria include both inclusion criteria (must have for a person to participate) and exclusion criteria (prevent a person from participating).
Review the exact criteria from the registry or the sponsor before making a decision to participate. The following values may be available on the portal:
Sex: an eligibility criteria based on biological characteristics. Information in the portal is based on available data and will default to 'all' when no other data is available.
Age: The age a person must be to participate in the clinical trial.
Accepts Healthy Volunteers: People who do not have the disease or condition can participate in the clinical trial.
Sex:
ALL
Accepts healthy volunteers:
No
Locations
Alberta
Alberta Dermasurgery Centre /ID# 275945
Edmonton, Alberta, T6G 1C3
Active, not recruiting
Beacon Dermatology /ID# 254564
Calgary, Alberta, T3A 2N1
Active, not recruiting
Care Clinic - Red Deer - Taylor Drive /ID# 276063
Red Deer, Alberta, T4P 1K4
Active, not recruiting
Dermatology Research Institute - Blackfoot Trail /ID# 261413
Calgary, Alberta, T2J 7E1
Active, not recruiting
Rejuvenation Dermatology - Edmonton Downtown /ID# 254715
Edmonton, Alberta, T5J 3S9
Active, not recruiting
British Columbia
Dr. Chih-ho Hong Medical Inc. /ID# 254378
Surrey, British Columbia, V3R 6A7
Active, not recruiting
Enverus Medical Research /ID# 254380
Surrey, British Columbia, V3V 0C6
COMPLETED
Manitoba
Wiseman Dermatology Research /ID# 254117
Winnipeg, Manitoba, R3M 3Z4
Active, not recruiting
Newfoundland and Labrador
Karma Clinical Trials /ID# 254120
St. John's, Newfoundland and Labrador, A1A 4Y3
Active, not recruiting
Ontario
Derm Care Clinic /ID# 276065
Mississauga, Ontario, L4W 0C2
Active, not recruiting
DermEffects /ID# 254116
London, Ontario, N6H 5L5
Active, not recruiting
Diex Recherche Quebec Inc. /ID# 254381
Québec, Ontario, G1V 4T3
Active, not recruiting
LEADER Research /ID# 254379
Hamilton, Ontario, L8L 3C3
Active, not recruiting
Lynderm Research Inc /ID# 254713
Markham, Ontario, L3P 1X2
Active, not recruiting
Research Toronto /ID# 255273
Toronto, Ontario, M4W 2N4
Active, not recruiting
Ryan Clinical Research Inc /ID# 254714
Newmarket, Ontario, L3Y 5G8
Active, not recruiting
York Dermatology Clinic and Research Centre /ID# 254115
Richmond Hill, Ontario, L4C 9M7
Active, not recruiting
Quebec
CHU Sainte-Justine /ID# 254118
Montreal, Quebec, H3T 1C5
Active, not recruiting
Dre Angelique Gagne-Henley M.D. inc. /ID# 255632
Saint-Jérôme, Quebec, J7Z 7E2
Active, not recruiting
Saskatchewan
SkinSense Dermatology /ID# 254119
Saskatoon, Saskatchewan, S7K 0H6
Active, not recruiting